Ronald A. Krasnow
Chief Operating Officer at Arch Oncology, Inc.
Ronald A. Krasnow active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Relypsa 106 LLC | Corporate Officer/Principal | - | - |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Chief Operating Officer | 15/11/2020 | - |
Career history of Ronald A. Krasnow
Former positions of Ronald A. Krasnow
| Companies | Position | Start | End |
|---|---|---|---|
Symyx Technologies, Inc.
 Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 31/12/1996 | - |
Fish & Neave LLP
 Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | General Counsel | 31/12/1989 | 31/12/1996 |
| VYNE THERAPEUTICS INC. | Compliance Officer | 31/12/2018 | - |
| General Counsel | 31/12/2018 | - | |
US Patent & Trademark Office
 US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Corporate Officer/Principal | - | - |
| RELYPSA INC | General Counsel | 30/09/2007 | - |
| Corporate Secretary | 30/09/2007 | - |
Training of Ronald A. Krasnow
| University of Michigan | Undergraduate Degree |
| George Washington University Law School | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| General Counsel | 3 |
| Corporate Officer/Principal | 3 |
| Corporate Secretary | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
Symyx Technologies, Inc.
Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA. | Technology Services |
US Patent & Trademark Office
US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Government |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
Fish & Neave LLP
Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | Commercial Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
| Relypsa 106 LLC |
- Stock Market
- Insiders
- Ronald A. Krasnow
- Experience
